Hold till at least $0.25-$0.50. Here is why? It will get

New Post Public Reply Private Reply Replies (0) Message Board
xyz1002
Hold till at least $0.25-$0.50. Here is why?

It will get there much sooner than anyone can imagine.

1) Ignore the OS. The float is very small. No one knows the float. The last reported float was like under 100M. From my 18 yrs of investment, if I had to take a wild guess, I will bet it is below 300M or maybe below 200M range. A good measure is when you see a stock moves 100% in one-day with whatever the volume is, the float is likely around that number. In other words, a general rule of thumb is a $1 stock will become $2 when the entire float churns. That is not valid for trips (0.0001-0.0002 types), however.

2) For SPCL most people like myself are holding for long-term, so the real available float is getting smaller every day. I am thinking there are quite a few people who are holding shares like myself.

3) Then you have traders who are buying and selling, taking their investment out and holding what they call the "free shares" for the long haul. They are carrying no risk at this point as they got the investment out. My guess is as the pps keeps moving up this crowd will get more and more making the available float even smaller.

4) So the pps will move up much faster and faster and once it reaches $0.05 range

5) The company is doing a RS with clear intent for up-listing. I have no doubt in my mind. Read below why. The OS after the RS will be a tiny 18M and the float maybe 2-3 M shares. After the RS and up-listing the stock will sky rocket and I for one plan to hold it for very long time. I am hoping that it will become a long-term investment. That is my goal.

6) Ignore the revenue and don't even try to do xPEG multiple. Private companies which are Silicon Valley VC-backed (I work in that space for living) gets 100x-500x revenue valuation. Revenue right now is irrelevant.

7) What is relevant is their “PROJECTED” growth rate. That will be the key piece of information one has to look out for when it comes out after or during the Uplisting.

8) They are the market leader in this space now which is another key point for valuation. That's why Uber is > $65 Billion valuation now.

9) My guess is with 18M OS after the RS and Uplisting if they can get say $900M valuation, that will put the pre-split pps of $0.50, 50X from here

10) I am thinking that is their goal. If they get $1B-$2B valuation, then at that point they can do a secondary and raise $200-$500M easy say at $100 a piece at that point.

11) So I am thinking we may be at $0.50 range by the time the Uplisting happens and that translate to $50 a piece after RS and a market cap of $900M.

12) btw- don't look at the app store for ranking. This is primarily a B2B, SaS type model Not a WhatsApp type for consumers. So the AppStore ranking is irrelevant.

These are all my assumption as I work with Startups, valuation and fund raising on a daily basis. I am assuming that these are a bunch of serious professionals with high level of ethics NOT some pinky scammers. All things points to the fact that they are serious and trying to do it right.

Will I be wrong? Maybe! I have been wrong in the past most definitely in the OTC land. So I play what I can gamble. I lost over $150K in one stupid Biotech pink stock many years ago. I actually visited their lab before making such huge investment. But the CEO basically changed. He threw ethics out the door when the time came and diluted the crap out of it.

I don't see any sign of that happening now. Not until the RS and uplisting. They can and will do a secondary pretty much guaranteed but by that time the pps will be $100 is my guess.

if you listen to the noise makers or try to day trade then you will miss out on the big gains. The noise makers have been making noise from 0.003 area and becoming louder everyday as they regret not buying. There will be many times it will gap up and those gaps won’t fill. Happens all the time when a stock is in strong upward move.

But OTC is and will be always a gamble.

Good Luck with whatever you do.
P.S: I had posted this on iHub long time ago

Solaris Power Cells, Inc (SPCL) Stock Research Links

SPCL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PAG Secures $355M to Accelerate Aggressive Growth

Updated Category News Views 4

Platform Accounting's Bold Expansion Move When you hear about a $355 million strategic financing round, it paints a picture of company ambitions colored in big, bold strokes. Platform Accounting Group (PAG) has managed to secure such a hefty financial backing from Treville Capital Group, taking a serious shot at expanding its footprint and offerings. This is no small...

Continue Reading
Tutoring America Champions Educational Equity with Grants

Updated Category News Views 7

Bolstering Educational Support for Low-Income Students In a world where opportunities hang on the thread of education, Tutoring America stands as a beacon for those left behind. This nonprofit tackles the education gap head-on, aiming to uplift low-income kids before they hit high school turbulence. Frankly, what they're doing is more than just good work—it's laying the...

Continue Reading
Saddleback's Bold Doula Program: A Game Changer

Updated Category News Views 10

Revolutionizing Maternity Support at Saddleback Saddleback Medical Center in Laguna Hills, California, is stirring the waters with its groundbreaking expansion in maternity services. For the first time, an Orange County hospital—The Women’s Hospital at MemorialCare Saddleback Medical Center—is offering complimentary, around-the-clock in-house doulas. Not a luxury,...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 6

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
JELD-WEN Schedules Q3 2026 Earnings Call Amid Global Reach

Updated Category News Views 4

Looking Ahead: JELD-WEN's Q3 Results Exploration Alright folks, buckle up. JELD-WEN Holding, Inc., the name any DIY'er worth their salt recognizes for doors and windows, has set the stage for unveiling its third quarter 2026 performance. They've earmarked November 3 post-market for us to comb through the numbers, and they're wasting no time by getting on a conference call...

Continue Reading
M&T Bank Declares Quarterly Preferred Dividends

Updated Category News Views 3

No Surprises Here—M&T Pays Out Big On Preferreds If there's one thing the market just loves to see amid all this noise and chatter, it's cash coming back to shareholders. M&T Bank Corporation, a seasoned player in the financial sector, is keeping its shareholders happy with some neat quarterly preferred stock dividends. Now, if you've been poking around the NYSE:MTB...

Continue Reading
IBM Backs Leena AI: Shaping Enterprise Automation

Updated Category News Views 9

IBM's Strategic Bet on Enterprise Automation Diving into the blazing 2026 market, IBM Ventures has thrown its weight behind Leena AI, an enterprise agentic AI firm that's out to shake things up. You see, the name of the game isn't just flashy AI chatbots anymore. Companies like Leena AI are setting their sights on the back-office grunt work—the lifeblood operations in...

Continue Reading
SQUID Platforms on CDAO Tradewinds Marketplace

Updated Category News Views 1

Old School Meets New Tech: SQUID's 'Awardable' Moment In an era drowning in data, IESE Solutions throws us a lifeline with its SQUID platform—assessed 'Awardable' and now live on the Department of War's Chief Digital and Artificial Intelligence Office's (CDAO) Tradewinds Solutions Marketplace. Sounds technical, right? Well, let’s dive into why it matters for those...

Continue Reading
MEDITECH and Lifemed AI Join Forces on Healthcare AI

Updated Category News Views 1

Lifemed AI and MEDITECH: A New Chapter in Healthcare You’d think by now the healthcare systems would be catching a break with technology, but here comes another twist. Lifemed AI and MEDITECH have banded together to tackle the notorious issue of claim denials head-on. Picture this: billions squandered every year because of avoidable administrative slip-ups. That's money...

Continue Reading
ALS.Community Launches Free Online Support Platform

Updated Category News Views 7

A Long Path to Connection Sometimes it's easy to forget the power a community can wield until you see one rally around a cause. The launch of ALS.Community isn't just a digital debut; it's a testament to how collective understanding can be a lifeline. For folks grappling with amyotrophic lateral sclerosis (ALS), beating solitude is often half the battle. Founder Jeff...

Continue Reading

Top 5 Most Recently Viewed Articles

Florida Homeowners Beware: Insurers May Leave You High and Dry

Updated Category News Views 172

Florida Homeowners Face Insurance Challenges After Hurricanes In the aftermath of hurricanes Helene and Milton, homeowners in Florida are encountering serious hurdles when seeking compensation from their insurance companies. Weiss Ratings, a reputable independent rating agency, has highlighted a troubling trend where legitimate claims are being unjustly denied. High Rate...

Continue Reading
Excelerate Energy Achieves New 52-Week High Amid Growth

Updated Category News Views 57

Excelerate Energy Reaches New 52-Week High Excelerate Energy Inc. (EE) has achieved a significant milestone, with its stock climbing to a new 52-week high of $20.67. This impressive jump, representing a 14.63% increase year-over-year, reflects growing investor confidence in the company’s strategic position and potential for future growth. At a time when the energy...

Continue Reading
Luna Innovations Shareholder Rights and Legal Guidance

Updated Category News Views 169

Understanding Shareholder Rights for Luna Innovations Inc. As a shareholder of Luna Innovations Incorporated (OTC: LUNA), it is crucial to know your rights and available options in ensuring that your interests are represented. Engaging with legal advisors can be a pivotal step in safeguarding your investment and holding parties accountable for any potential breaches of...

Continue Reading
Rakovina Therapeutics Highlights AI Drug Development at Neuro-Oncology Event

Updated Category News Views 147

Rakovina Therapeutics Launches AI-Driven Initiatives in Cancer Research VANCOUVER, British Columbia — Rakovina Therapeutics Inc. (TSX-V: RKV) is excited to announce a significant upcoming opportunity to showcase its cutting-edge research in the field of cancer therapies. The company will be presenting a poster at an esteemed annual gathering focused on neuro-oncology,...

Continue Reading
Ascend Performance Materials Launches High-Purity Production

Updated Category News Views 260

Ascend Performance Materials Starts High-Purity Acrylonitrile Production Ascend Performance Materials has recently announced an exciting new phase in its production capabilities. The company is now producing high-purity acrylonitrile at its Chocolate Bayou facility. This advancement comes after the successful installation and commissioning of state-of-the-art purification...

Continue Reading